The US Army has selected UK skin and hair restoration specialist Intercytex to develop regenerative medicine for the treatment of battlefield injuries such as burns and skin loss, as part of its Armed Forces Institute of Regenerative Medicine (AFIRM) project.
Therapies developed by AFIRM will also be used to treat trauma and burns patients in the general public, says Thomson Financial.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
By staff writer
